CYCLIN-DEPENDENT KINASE INHIBITORS - NEW THERAPEUTIC OPTION FOR PATIENTS WITH HORMONE-DEPENDENT HER2-NEGATIVE BREAST CANCER: CLINICAL EXPERIENCE

Autor:	R.I. Kunafina Kunafina, D.D. Sakaeva Sakaeva, A.I. Iskhakova Iskhakova, Ufa Bashkir Republican Clinical Oncological Dispensary
Rok vydání:	2018
Předmět:	Breast cancer business.industry HER2 negative Cancer research medicine medicine.disease business Cyclin-Dependent Kinase Inhibitors Hormone
Zdroj:	Pharmateca. :45-49
ISSN:	2414-9128
DOI:	10.18565/pharmateca.2018.7.45-49
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::85d840bcdc7920052cdfdaa6a3e20b0e https://doi.org/10.18565/pharmateca.2018.7.45-49 Zobrazit plný text záznamu